The identification of affinity peptide ligands specific to the variable region ofhuman antibodies
Authors:
- 1 January 2014
- journal article
- Published by Biomedical Research Press in Biomedical Research
- Vol. 35 (2) , 105-116
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 28 references indexed in Scilit:
- Comprehensive Experimental and Computational Analysis of Binding Energy Hot Spots at the NF-κB Essential Modulator/IKKβ Protein–Protein InterfaceJournal of the American Chemical Society, 2013
- Bispecific T-Cell Engaging Antibodies for Cancer TherapyCancer Research, 2009
- Monoclonal antibody therapy of cancerNature Biotechnology, 2005
- Flexibility—the guiding principle for antibody manufacturingNature Biotechnology, 2005
- Engineered antibody fragments and the rise of single domainsNature Biotechnology, 2005
- Convergent Solutions to Binding at a Protein-Protein InterfaceScience, 2000
- Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancerClinical Therapeutics, 1999
- Identification of peptides that bind to the constant region of a humanized IgG1 monoclonal antibody using phage displayJournal of Molecular Recognition, 1998
- Monoclonal anti‐VH antibodies recognize a common VH determinant expressed on immunoglobulin heavy chains from various speciesEuropean Journal of Immunology, 1983
- Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-SepharoseImmunochemistry, 1978